Banner Payson Medical Center | |
807 South Ponderosa Drive, Payson, Arizona 85541 | |
(928) 474-3222 | |
Name | Banner Payson Medical Center |
---|---|
Type | Critical Access Hospital |
Location | 807 South Ponderosa Drive, Payson, Arizona |
Ownership | Voluntary non-profit - Other |
Emergency Services | No |
Medicare ID (CCN) | 031318 |
NPI Number | 1063893121 |
Organization Name | BANNER HEALTH |
Doing Business As | BANNER PAYSON MEDICAL CENTER |
Address | 807 S Ponderosa St, Payson, AZ 85541 |
Hospital Type | General Acute Care Hospital |
Phone Number | 928-474-3222 |
News Archive
Myomo, Inc. has announced that the company received U.S. Food and Drug Administration (FDA) 510(k) clearance to market the Myomo e100 NeuroRobotic System. Myomo's first product is a wearable, portable therapeutic modality designed to allow patients to self initiate and control movement of partially paralyzed limbs using their own biological signals.
Genetic mutation can disrupt the way human cells make proteins, which in turn leads to inherited disease. David Bedwell, a professor in the University of Alabama at Birmingham (UAB) Department of Microbiology, says scientists are closer than ever to producing drugs that fix this disrupted-protein pathway and drastically improving treatment of genetic disease.
The National Science Foundation has awarded $550,000 to fund a collaborative new research project to develop a noninvasive, computational modeling technology for assessing the likelihood of a heart attack in patients with high levels of plaque buildup in their arteries - the primary cause of heart attack in the U.S. today.
Dune Medical Devices, Inc., announced today that it has received an Approvable Letter for its Premarket Approval Application (PMA) from the Food and Drug Administration. The Approvable Letter states that the MarginProbe System PMA is approvable subject to final agreement with FDA on the design of the required Post Approval Study.
Continuing medical education, newsletters and resource guides were only partially successful in changing the way that pediatricians handled behavioral health problems, according to a follow-up study at Wake Forest University School of Medicine.
› Verified 7 days ago
NPI Number | 1063923340 |
Organization Name | BANNER HEALTH |
Doing Business As | BANNER PAYSON MEDICAL CENTER |
Address | 807 S Ponderosa St, Payson, AZ 85541 |
Hospital Type | General Acute Care Hospital - Critical Access |
Phone Number | 928-471-3222 |
News Archive
Myomo, Inc. has announced that the company received U.S. Food and Drug Administration (FDA) 510(k) clearance to market the Myomo e100 NeuroRobotic System. Myomo's first product is a wearable, portable therapeutic modality designed to allow patients to self initiate and control movement of partially paralyzed limbs using their own biological signals.
Genetic mutation can disrupt the way human cells make proteins, which in turn leads to inherited disease. David Bedwell, a professor in the University of Alabama at Birmingham (UAB) Department of Microbiology, says scientists are closer than ever to producing drugs that fix this disrupted-protein pathway and drastically improving treatment of genetic disease.
The National Science Foundation has awarded $550,000 to fund a collaborative new research project to develop a noninvasive, computational modeling technology for assessing the likelihood of a heart attack in patients with high levels of plaque buildup in their arteries - the primary cause of heart attack in the U.S. today.
Dune Medical Devices, Inc., announced today that it has received an Approvable Letter for its Premarket Approval Application (PMA) from the Food and Drug Administration. The Approvable Letter states that the MarginProbe System PMA is approvable subject to final agreement with FDA on the design of the required Post Approval Study.
Continuing medical education, newsletters and resource guides were only partially successful in changing the way that pediatricians handled behavioral health problems, according to a follow-up study at Wake Forest University School of Medicine.
› Verified 7 days ago
NPI Number | 1881665545 |
Organization Name | PAYSON HOSPITAL CORPORATION |
Doing Business As | PAYSON REGIONAL MEDICAL CENTER |
Address | 807 S Ponderosa St, Payson, AZ 85541 |
Hospital Type | General Acute Care Hospital |
Phone Number | 928-474-3222 |
News Archive
Myomo, Inc. has announced that the company received U.S. Food and Drug Administration (FDA) 510(k) clearance to market the Myomo e100 NeuroRobotic System. Myomo's first product is a wearable, portable therapeutic modality designed to allow patients to self initiate and control movement of partially paralyzed limbs using their own biological signals.
Genetic mutation can disrupt the way human cells make proteins, which in turn leads to inherited disease. David Bedwell, a professor in the University of Alabama at Birmingham (UAB) Department of Microbiology, says scientists are closer than ever to producing drugs that fix this disrupted-protein pathway and drastically improving treatment of genetic disease.
The National Science Foundation has awarded $550,000 to fund a collaborative new research project to develop a noninvasive, computational modeling technology for assessing the likelihood of a heart attack in patients with high levels of plaque buildup in their arteries - the primary cause of heart attack in the U.S. today.
Dune Medical Devices, Inc., announced today that it has received an Approvable Letter for its Premarket Approval Application (PMA) from the Food and Drug Administration. The Approvable Letter states that the MarginProbe System PMA is approvable subject to final agreement with FDA on the design of the required Post Approval Study.
Continuing medical education, newsletters and resource guides were only partially successful in changing the way that pediatricians handled behavioral health problems, according to a follow-up study at Wake Forest University School of Medicine.
› Verified 7 days ago
Able to receive lab results electronically | Yes |
Able to track patients' lab results, tests, and referrals electronically between visits | Yes |
News Archive
Myomo, Inc. has announced that the company received U.S. Food and Drug Administration (FDA) 510(k) clearance to market the Myomo e100 NeuroRobotic System. Myomo's first product is a wearable, portable therapeutic modality designed to allow patients to self initiate and control movement of partially paralyzed limbs using their own biological signals.
Genetic mutation can disrupt the way human cells make proteins, which in turn leads to inherited disease. David Bedwell, a professor in the University of Alabama at Birmingham (UAB) Department of Microbiology, says scientists are closer than ever to producing drugs that fix this disrupted-protein pathway and drastically improving treatment of genetic disease.
The National Science Foundation has awarded $550,000 to fund a collaborative new research project to develop a noninvasive, computational modeling technology for assessing the likelihood of a heart attack in patients with high levels of plaque buildup in their arteries - the primary cause of heart attack in the U.S. today.
Dune Medical Devices, Inc., announced today that it has received an Approvable Letter for its Premarket Approval Application (PMA) from the Food and Drug Administration. The Approvable Letter states that the MarginProbe System PMA is approvable subject to final agreement with FDA on the design of the required Post Approval Study.
Continuing medical education, newsletters and resource guides were only partially successful in changing the way that pediatricians handled behavioral health problems, according to a follow-up study at Wake Forest University School of Medicine.
› Verified 7 days ago
Banner Payson Medical Center Critical Access Hospital Location: 807 South Ponderosa Drive, Payson, Arizona 85541 Phone: (928) 474-3222 |